Optimizing biologic therapy in the adjuvant setting: HER2-targeting agents and antiangiogenesis
Sandra M. Swain，Director, Washington Cancer Institute，Washington Hospital Center
Professor of Medicine，Georgetown University，Washington DC
编辑: ludongcn 作者:丁香园通讯员
以下网友留言只代表网友个人观点，不代表网站观点
